U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H19N
Molecular Weight 129.2432
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OCTYLAMINE

SMILES

CCCCCCCCN

InChI

InChIKey=IOQPZZOEVPZRBK-UHFFFAOYSA-N
InChI=1S/C8H19N/c1-2-3-4-5-6-7-8-9/h2-9H2,1H3

HIDE SMILES / InChI

Molecular Formula C8H19N
Molecular Weight 129.2432
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Octylamine is used to prepare different chemical compounds, including inhibitors of myeloperoxidase. In addition, this compound was studied as a novel extractant for the automated salting-out assisted liquid-liquid microextraction.

Approval Year

PubMed

PubMed

TitleDatePubMed
Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates.
2001 Jan
Evidence that RDX biodegradation by Rhodococcus strain DN22 is plasmid-borne and involves a cytochrome p-450.
2002
Adsorption from the organic phase in the octanoic acid-octylamine-silica system.
2002 Aug 15
Hydrolysis and amine-capping in a glycol solvent as a route to soluble maghemite gamma-Fe2O3 nanoparticles.
2002 May 21
Extraction of heavy metals by amines adsorbed onto silica gel.
2003
Versatile routes to C-2- and C-6-functionalized glucose derivatives of iminodiacetic acid.
2003 Jan 24
Site of action of fatty acids and other charged lipids on BKCa channels from arterial smooth muscle cells.
2003 Mar
A highly toxic morphine-3-glucuronide derivative.
2004 Feb 23
Separation and conductimetric detection of C1-C7 aliphatic monocarboxylic acids and C1-C7 aliphatic monoamines on unfunctionized polymethacrylate resin columns.
2004 Jun 11
Metabolism of N,N',N"-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the inactivation of both isoforms by two distinct mechanisms.
2004 Sep
Structure analysis of intercalated layer silicates: combination of molecular simulations and experiment.
2004 Sep 1
Simultaneous determination of cefepime and grepafloxacin in human urine by high-performance liquid chromatography.
2004 Sep 21
Perpendicular magnetization in self-assembled films of citrate-capped gamma-Fe2O3 nanocrystals on Si(100) surfaces.
2005 Apr
First reaction of a bare silicon surface with acid chlorides and a one-step preparation of acid chloride terminated monolayers on scribed silicon.
2005 Mar 15
Alkane-induced expression, substrate binding profile, and immunolocalization of a cytochrome P450 encoded on the nifD excision element of Anabaena 7120.
2005 Mar 24
Synthesis and characterization of novel blood-compatible soluble chemically cross-linked polyurethanes with excellent mechanical performance for biomedical applications.
2005 May-Jun
Study of electron donor-acceptor complexes of tri-n-octyl amine with [60]- and [70]fullerenes and some other electron acceptors by absorption spectrophotometric method.
2006 Feb
Simple method for the stretching and alignment of single adsorbed synthetic polycations.
2006 Jul
Bis(n-octylamino)perylene-3,4:9,10-bis(dicarboximide)s and their radical cations: synthesis, electrochemistry, and ENDOR spectroscopy.
2006 Mar 3
Synthesis of the docosanasaccharide arabinan domain of mycobacterial arabinogalactan and a proposed octadecasaccharide biosynthetic precursor.
2007 Aug 15
Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress.
2007 Dec 21
New polyamine-sensitive inhibitors of the NMDA receptor: syntheses and pharmacological evaluation.
2007 Feb
Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study.
2007 Jan 17
Manipulating the self-assembling process to obtain control over the morphologies of copper oxide in hydrothermal synthesis and creating pores in the oxide architecture.
2007 May 22
Low temperature synthesis of colloidal CdSe quantum dots.
2007 Nov
Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings.
2008 Apr 15
Ligand bonding and dynamics on colloidal nanocrystals at room temperature: the case of alkylamines on CdSe nanocrystals.
2008 Apr 30
One-step rapid determination and purification of puerarin from Radix puerariae by n-octylamine-modified poly(methacrylate-co-ethylene dimethacrylate) monolith.
2008 Aug 1
Studies on 1-alkylamine adduct formation in electrospray ionization mass spectrometry for quantitative analysis.
2008 Aug 5
Substrate specificity of a long-chain alkylamine-degrading Pseudomonas sp isolated from activated sludge.
2008 Feb
Reactivity of hydrogen with solid-state films of alkylamine- and tetraoctylammonium bromide-stabilized Pd, PdAg, and PdAu nanoparticles for sensing and catalysis applications.
2008 Jan 16
Solvent-dependent, low-temperature solution phase synthesis of FePt nanowires.
2008 Jul
Silica encapsulated CdS tabular nanocomposites via a template directed agglomeration mechanism.
2008 Nov
Automated potentiometric titrations in KCl/water-saturated octanol: method for quantifying factors influencing ion-pair partitioning.
2009 Apr 1
(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.
2009 Aug
Liquid-liquid extraction/separation of platinum(IV) and rhodium(III) from acidic chloride solutions using tri-iso-octylamine.
2009 Aug 30
Revisiting tungsten trioxide hydrates (TTHs) synthesis--is there anything new?
2009 Jul 20
Silica nanoparticles grown and stabilized in organic nonalcoholic media.
2009 Jul 7
Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis.
2009 May 29
Iron oxide-based nanomagnets in nanomedicine: fabrication and applications.
2010
Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism.
2010 Dec 14
CdO/ZnO core/shell nanostructures grown from single molecular precursors.
2010 Mar
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
2010 May 24
N-(3-Octyl-4-oxo-1,3-thia-zolidin-2-yl-idene)benzamide.
2010 Nov 24
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 06:08:20 GMT 2023
Edited
by admin
on Sat Dec 16 06:08:20 GMT 2023
Record UNII
SF0V8U4T67
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OCTYLAMINE
Systematic Name English
GENAMIN 8R
Brand Name English
OCTANAMINE
Systematic Name English
MONOOCTYLAMINE
Systematic Name English
N-OCTYLAMINE
Systematic Name English
1-AMINOOCTANE
Systematic Name English
1-OCTYLAMINE
Systematic Name English
CAPRYLAMINE
Common Name English
NSC-9824
Code English
OCTAN-1-AMINE
Systematic Name English
1-OCTANAMINE
Systematic Name English
CAPRYLYLAMINE
Systematic Name English
Code System Code Type Description
NSC
9824
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
ECHA (EC/EINECS)
203-916-0
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
EPA CompTox
DTXSID8021939
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
PUBCHEM
8143
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
CHEBI
7728
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
CAS
111-86-4
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
MESH
C008699
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
FDA UNII
SF0V8U4T67
Created by admin on Sat Dec 16 06:08:20 GMT 2023 , Edited by admin on Sat Dec 16 06:08:20 GMT 2023
PRIMARY
Related Record Type Details
LABELED -> NON-LABELED